So, the research and the party line right now would suggest it is safe to give GLP-1 agonists to patients who have had thyroid cancer or who have thyroid nodules
First, due to the lack of detailed individual information regarding sex, mental and physical conditions, and other concomitant diseases, subgroups that may show more beneficial effects of antioxidants could not be selected (Lu et al., 2022)
Trust our medical spa experts to help you create the body you want.
Most patients receive a layered combination, not a single treatment
The medication is a GLP-1 receptor agonist that stimulates insulin secretion, suppresses glucagon, and slows gastric emptying
A healthcare provider may prescribe a compounded drug if determined that it is medically appropriate and necessary for you